Clinical Trial Update: Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

View source ↗

Summary

A completed clinical trial evaluated the tolerability and safety of Allergovac Poliplus in polysensitized patients with allergic rhinitis or rhinoconjunctivitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Rhinoconjunctivitis

Drugs mentioned

• Allergovac Poliplus

Snippet

Sponsor: Roxall Medicina España S.A | Conditions: Allergic Rhinitis, Rhinoconjunctivitis | Status: COMPLETED